This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1y2n

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (16:22, 3 November 2021) (edit) (undo)
 
(8 intermediate revisions not shown.)
Line 1: Line 1:
{{Theoretical_model}}
{{Theoretical_model}}
-
{{Seed}}
 
-
[[Image:1y2n.png|left|200px]]
 
-
<!--
+
==MODEL STRUCTURE OF TRASTUZUMAB COMPLEXED WITH H98, A MIMIC ANTIGEN EPITOPE OF HER-2==
-
The line below this paragraph, containing "STRUCTURE_1y2n", creates the "Structure Box" on the page.
+
<StructureSection load='1y2n' size='340' side='right'caption='[[1y2n]]' scene=''>
-
You may change the PDB parameter (which sets the PDB file loaded into the applet)
+
== Structural highlights ==
-
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
+
<table><tr><td colspan='2'>For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1Y2N FirstGlance]. <br>
-
or leave the SCENE parameter empty for the default display.
+
</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1y2n FirstGlance], [https://www.ebi.ac.uk/pdbsum/1y2n PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1y2n ProSAT]</span></td></tr>
-
-->
+
</table>
-
{{STRUCTURE_1y2n| PDB=1y2n | SCENE= }}
+
<div style="background-color:#fffaf0;">
 +
== Publication Abstract from PubMed ==
 +
Trastuzumab, a humanized antibody to HER-2, has been shown to be effective in the treatment of breast cancer in which HER-2 overexpression and metastasis occurs. In our search for an effective mimic epitope of HER-2 binding with trastuzumab and to develop HER-2 peptide vaccine, we screened a phage display 12-mer peptide library with trastuzumab as the target. A mimetic peptide (mimotope) H98 (LLGPYELWELSH) that could specifically recognize trastuzumab was isolated. The DNA encoding peptide H98 was cloned and expressed as the fusion protein GST-H98 in Escherichia coli BL21. The purified GST-H98 could specifically bind to trastuzumab and block the binding of trastuzumab to HER-2 protein. Moreover, H98 could significantly block the function of trastuzumab inhibiting the growth of cancer cells. Mice that were immunized with GST-H98 made specific antibody to H98 as well as to HER-2. In addition, T-cell proliferation occurred in mice immunized with GST-H98. Although no sequence homology was found between H98 and HER-2, through the use of structure analysis we were able to determine that peptide H98 contributed to a conformational epitope of HER-2. Furthermore, we determined that the last two amino acids at the C terminus, and the third together with the fourth amino acid at the N terminus of peptide H98 are critical to the binding of H98 to trastuzumab. As a result, we conclude that peptide H98 has potential for being developed as a HER-2 vaccine for biotherapy of cancer with HER-2 overexpression.
-
===MODEL STRUCTURE OF TRASTUZUMAB COMPLEXED WITH H98, A MIMIC ANTIGEN EPITOPE OF HER-2===
+
A novel peptide isolated from a phage display peptide library with trastuzumab can mimic antigen epitope of HER-2.,Jiang B, Liu W, Qu H, Meng L, Song S, Ouyang T, Shou C J Biol Chem. 2005 Feb 11;280(6):4656-62. Epub 2004 Nov 9. PMID:15536075<ref>PMID:15536075</ref>
-
 
+
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
-
<!--
+
</div>
-
The line below this paragraph, {{ABSTRACT_PUBMED_15536075}}, adds the Publication Abstract to the page
+
<div class="pdbe-citations 1y2n" style="background-color:#fffaf0;"></div>
-
(as it appears on PubMed at http://www.pubmed.gov), where 15536075 is the PubMed ID number.
+
== References ==
-
-->
+
<references/>
-
{{ABSTRACT_PUBMED_15536075}}
+
__TOC__
-
 
+
</StructureSection>
-
==About this Structure==
+
[[Category: Theoretical Model]]
-
Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1Y2N OCA].
+
[[Category: Large Structures]]
-
 
+
-
==Reference==
+
-
<ref group="xtra">PMID:15536075</ref><references group="xtra"/>
+
[[Category: Jiang, B]]
[[Category: Jiang, B]]
[[Category: Liu, W]]
[[Category: Liu, W]]
Line 32: Line 29:
[[Category: Shou, C]]
[[Category: Shou, C]]
[[Category: Song, S]]
[[Category: Song, S]]
- 
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Apr 8 09:02:32 2010''
 

Current revision

Theoretical Model: The protein structure described on this page was determined theoretically, and hence should be interpreted with caution.

MODEL STRUCTURE OF TRASTUZUMAB COMPLEXED WITH H98, A MIMIC ANTIGEN EPITOPE OF HER-2

PDB ID 1y2n

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1y2n"
Personal tools